Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Min Wu Chao (Contributor)
Li Hsun Chang (Contributor)
Huang Ju Tu (Contributor)
Chao-Di Chang (Contributor)
Mei-Jung Lai (Contributor)
Ying Yi Chen (Creator)
Jing-Ping Liou (Creator)
Che Ming Teng (Contributor)
Shiow-Lin Pan (Contributor)

Dataset

1 Article

1 results

2019
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. W., Chang, L. H., Tu, H. J., Chang, C. D., Lai, M. J., Chen, Y. Y., Liou, J. P., Teng, C. M. & Pan, S. L., May 29 2019, In: Clinical Epigenetics. 11, 1, p. 85 85.
Research output: Contribution to journal › Article › peer-review

Open Access
15 Citations (Scopus)